Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model

Detalles Bibliográficos
Autores principales: Swearingen, Bruce J., Graves, Scott S., Storb, Rainer, Mathes, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
PSRC 2018 Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959703/
http://dx.doi.org/10.1097/01.GOX.0000533905.72280.11
_version_ 1783324452570791936
author Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
author_facet Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
author_sort Swearingen, Bruce J.
collection PubMed
description
format Online
Article
Text
id pubmed-5959703
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-59597032018-05-29 Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model Swearingen, Bruce J. Graves, Scott S. Storb, Rainer Mathes, David W. Plast Reconstr Surg Glob Open PSRC 2018 Abstract Supplement Wolters Kluwer Health 2018-05-07 /pmc/articles/PMC5959703/ http://dx.doi.org/10.1097/01.GOX.0000533905.72280.11 Text en Copyright © 2018 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle PSRC 2018 Abstract Supplement
Swearingen, Bruce J.
Graves, Scott S.
Storb, Rainer
Mathes, David W.
Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title_full Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title_fullStr Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title_full_unstemmed Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title_short Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model
title_sort abstract 40: amd3100 (plerixafor) as a single-dose stem cell mobilizing agent in vascularized composite tissue allograft (vca) transplantation in a canine model
topic PSRC 2018 Abstract Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959703/
http://dx.doi.org/10.1097/01.GOX.0000533905.72280.11
work_keys_str_mv AT swearingenbrucej abstract40amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninemodel
AT gravesscotts abstract40amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninemodel
AT storbrainer abstract40amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninemodel
AT mathesdavidw abstract40amd3100plerixaforasasingledosestemcellmobilizingagentinvascularizedcompositetissueallograftvcatransplantationinacaninemodel

Ejemplares similares